Presence of Breast Cancer Information Recorded in United Kingdom Primary Care Databases: Comparison of CPRD Aurum and CPRD GOLD (Companion Paper 1)

December 16, 2023Posted inCPRD, Recent work examples, Validation Studies
Journal: Clinical Epidemiology Authors: Katrina Wilcox Hagberg, Catherine Vasilakis-Scaramozza, Rebecca Persson, David Neasham, George Kafatos, Susan Jick NLM Citation: Hagberg KW, Vasilakis-Scaramozza C, Persson R, Neasham D, Kafatos G, Jick S. Presence of Breast Cancer…

Correctness and Completeness of Breast Cancer Diagnoses Recorded in UK CPRD Aurum and CPRD GOLD Databases: Comparison to Hospital Episode Statistics and Cancer Registry (Companion Paper 2)

December 16, 2023Posted inCPRD, Recent work examples, Validation Studies
Journal: Clinical Epidemiology Authors: Katrina Wilcox Hagberg, Catherine Vasilakis-Scaramozza, Rebecca Persson, David Neasham, George Kafatos, Susan Jick NLM Citation: Hagberg KW, Vasilakis-Scaramozza C, Persson R, Neasham D, Kafatos G, Jick S. Correctness and Completeness of…

Comparison of Rheumatoid Arthritis Information Recorded in UK CPRD Aurum and CPRD GOLD Databases (Companion Paper 3)

December 16, 2023Posted inCPRD, Recent work examples, Validation Studies
Journal: Clinical Epidemiology Authors: Catherine Vasilakis-Scaramozza, Katrina Wilcox Hagberg, Rebecca Persson, George Kafatos, Joe Maskell, David Neasham, Susan Jick NLM Citation: Vasilakis-Scaramozza C, Hagberg KW, Persson R, Kafatos G, Maskell J, Neasham D, Jick S. Comparison…

Incomplete capture of apremilast in Clinical Practice Research Datalink Aurum: An example of exposure misclassification of specialty treatments in United Kingdom general practice databases

October 2, 2023Posted inCPRD, Validation Studies
Journal: Pharmacoepidemiology and Drug Safety Authors: Rebecca Persson, Susan Jick NLM Citation: Persson R, Jick S. Incomplete capture of apremilast in Clinical Practice Research Datalink Aurum: An example of exposure misclassification…

Non-steroidal anti-inflammatory drugs and risk of myocardial infarction adjusting for use of proton pump-inhibitors in patients with no major risk factors: a nested case-control study in the UK Clinical Practice Research Datalink

December 15, 2022Posted inCPRD, Drug Safety Studies, Recent student studies conducted at BCDSP, Safety of other important drugs, Student Studies
Journal: European Heart Journal of Cardiovascular Pharmacotherapy Authors: Brenda N Baak, Susan S Jick NLM Citation: Baak BN, Jick SS. Non-steroidal anti-inflammatory drugs and risk of myocardial infarction adjusting for use…